MGMT immunoexpression in silent subtype 3 pituitary adenomas: Possible therapeutic implications

Michael E. Fealey, Bernd W. Scheithauer, Eva Horvath, Dana Erickson, Kalman Kovacs, Roger McLendon, Ricardo V. Lloyd

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'MGMT immunoexpression in silent subtype 3 pituitary adenomas: Possible therapeutic implications'. Together they form a unique fingerprint.

Medicine & Life Sciences